Brazil to export vaccine against measles, rubella

Brazil will produce a combined vaccine against measles and rubella exclusively for export to poor countries, mainly in Africa, its health minister said Monday.

Alexandre Padilha said the aim was to produce 30 million doses by 2017 for sale at a price of 54 US cents each. Currently such vaccines are made only in India.

Padilha made the announcement at an event in Rio where he announced that the government was inking an investment deal with the US Bill & Melinda Gates foundation to develop the .

He said his ministry would invest $727 million in construction of a state-of-the pharmaceutical plant at the Bio-Manguinhos Institute, a government institution located in Rio.

"This plant will generate employment, revenue, know-how, research and technological innovation in this country," he added.

"The agreement which we are signing provides more investments and buying guarantees, which makes it possible to export at the lowest cost," he said.

The Gates Foundation is meanwhile allocating $1.1 million for the project.

Measles was eradicated in Brazil in 2000 and (or German measles) in 2009.

But the diseases remain endemic in some countries.

In 2011, 158,000 people died of around the world, most of them in , according to data from the World Health Organization.

Meanwhile Carlos Gadelha, the health ministry's science and technology secretary said Latin America's dominant economic power also hopes to make headway toward developing the pentavalent vaccine and a vaccine against dengue fever.

The pentavalent vaccine simultaneously provides protection against five life threatening diseases - Diphtheria, Pertussis, Tetanus, Hepatitis B and Hib (Haemophilus influenza type b).

add to favorites email to friend print save as pdf

Related Stories

Timing of first dose of measles vaccine questioned

Oct 21, 2013

(HealthDay)—Children who receive the first dose of a two-dose schedule of measles vaccine at 12 to 13 months compared with 15 months or later have a greater risk of developing measles, according to a study ...

Recommended for you

FDA OKs Cubist antibiotic for serious infections

Dec 20, 2014

The Food and Drug Administration has approved a new medicine to fight complex infections in the abdomen and urinary tract, the fourth antibiotic the agency has approved since May.

Xtoro approved for swimmer's ear

Dec 18, 2014

(HealthDay)—Xtoro (finafloxacin otic suspension) eardrops have been approved by the U.S. Food and Drug Administration to treat swimmer's ear, clinically known as acute otitis externa.

Drug interaction identified for ondansetron, tramadol

Dec 18, 2014

(HealthDay)—In the early postoperative period, ondansetron is associated with increased requirements for tramadol consumption, according to a review and meta-analysis published online Dec. 10 in Anaesthesia.

New system targets germs in donated blood plasma

Dec 17, 2014

(HealthDay)—A new system designed to eliminate germs in donated blood plasma and reduce the risk of transmitting a plasma-borne infection has been approved by the U.S. Food and Drug Administration.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.